9,672 results found

WilmerHale's 2025 Venture Capital Report provides comprehensive analysis of US venture capital financing trends, examining SAFE financings, mega-rounds, and the impact of recent legislation on qualified small-business stock. The report explores convertible note terms, venture capital financing structures, and key factors shaping the venture capital landscape in the coming year.

Marcos Cortes and Jeff Wilson, Managing Directors of A&M's Corporate Transactions Group (CTG), discuss the future of corporate M&A and the latest groundbreaking strategies...

In an interview on CNBC with Andrew Ross Sorkin on Thursday, SEC Chair Jay Clayton addressed the recent SPAC frenzy.

Co-investing is in full stride these days with more LPs co-investing alongside the GP.

Verisk's $2.35 billion acquisition of AccuLynx faced unexpected FTC scrutiny, leading to a Delaware Court of Chancery ruling that prevented Verisk from abandoning the deal. Legal experts dissect the antitrust challenges, the FTC's novel "market reset" theory, and critical lessons for drafting merger agreements in an evolving regulatory landscape.

In this video, Managing Director Victoria Price discusses the potential changes to the taxation on executives in the Private Equity sector and the effects this may have on the industry...

The SEC does of course make changes to its rules and procedures but only rarely and never lightly. The universal proxy card, which made its debut recently, certainly does not come as a surprise.

In this episode of the Above Board podcast, Morrison Foerster partner and host Dave Lynn discusses shareholder activism with the firm's global Mergers & Acquisitions Group co-chairs...

In the second episode of this miniseries, sponsored by AlixPartners, PE leaders share how they're weathering operational and financial challenges.

On August 29, 2025, the staff of the SEC's Division of Corporation Finance announced that an updated version of the Financial Reporting Manual has been posted to reflect i) additional real estate...

Cooley advised Aeglea BioTherapeutics, a clinical-stage biotechnology company, on its acquisition of Spyre Therapeutics and concurrent private investment.

In this episode of AHLA's Speaking of Health Law podcast, John E. Kelly, Partner, Barnes & Thornburg LLP, and Kim H. Looney, Partner, K&L Gates LLP, discuss the current dynamics...

"The sustained surge of M&A activity, SPACs, de-SPACing and IPOs has major dealmakers scrambling to find enough associates to staff their deals, risking burnout for the associates they do have on staff."

In the classic 1972 film "The Godfather," Don Vito Corleone frequently gives his rivals an "offer they can't refuse."

McDermott's Antitrust M&A Snapshot is a resource for in-house counsel and others who deal with antitrust M&A issues but are not faced with these issues on a daily basis.

Under Section 262 of the Delaware General Corporation Law ("DGCL"), the Court is authorized to add simple or compound interest to the appraised value to a dissenting shareholder.

Fox Rothschild announced that it would be merging with the Minneapolis-based law firm of Oppenheimer Wolff & Donnelly LLP on January 4, 2016.